Frequency Exchange Launches Superhuman 2 Digital Premiere and Closes Final Private Placement Tranche

Frequency Exchange Corp. Began the worldwide digital release of Superhuman 2: The Rebirth, a four-part docuseries featuring its NIKKI Wellness Technology, on October 30, 2026, and closed the final tranche of a private placement for $60,282.75. TradingView carried the announcement.

Superhuman 2 Premiere and NIKKI's Role

The four-part series comes from filmmaker Caroline Cory and examines emerging perspectives on human potential, perception and cognitive performance, bringing together subject matter experts for research-driven insights on wellness approaches. NIKKI serves as the series' principal partner and is integrated throughout as an emerging wellness technology, giving audiences context on frequency-based wellness programs in observational settings.

The worldwide online premiere began at 12:00 P.M. PST on October 30, 2026, with live conversations and Q&A sessions featuring participants in the production. Stephen Davis, Frequency Exchange's CEO and founder of NIKKI Technology, took part in a live conversation and Q&A before the series premiere. Tickets are available at watch.superhuman2.com, and each ticket provides access to the complete series for seven days.

The release follows the series' Official Selection debut at the DaVinci International Film Festival on September 26, 2026, and a red-carpet global premiere in Beverly Hills on October 4, 2026. Davis framed the premiere as a visibility step: "Today's worldwide digital premiere represents an important visibility milestone for NIKKI and Frequency Exchange," he said. "NIKKI's prominent integration throughout Superhuman 2: The Rebirth, together with my participation in the live premiere, introduces the technology and our story to an international audience as we continue advancing our broader commercialization and market awareness strategies."

Final Tranche Brings Placement to $487,340.25

The company closed the second and final tranche of its non-brokered private placement, issuing 241,131 units at $0.25 per unit for proceeds of $60,282.75. Combined with the first tranche, the placement totals 1,949,361 units for aggregate proceeds of $487,340.25.

Each unit consists of one common share and one-half of one common share purchase warrant. Each warrant is exercisable at $0.40 for 12 months from issuance and is subject to an acceleration clause tied to a volume-weighted average trading price of at least $0.70 per common share for 10 consecutive trading days. Frequency Exchange issued 8,000 non-transferable finder's warrants and paid a cash commission of $2,000 to Research Capital Corp.. Net proceeds are expected to fund sales and marketing, inventory, technology and platform development, team growth, international expansion and general working capital.

Earlier Placement Tranche and Marketing Push

On September 11, 2026, TradingView reported that Frequency Exchange closed the first tranche of the private placement, issuing 1,708,230 units at $0.25 each for gross proceeds of $427,057. On September 10, 2026, FinanzNachrichten.de reported that the company announced marketing initiatives for NIKKI starting in September with US practitioner access, UAE expansion and Best Buy Marketplace, alongside a raise of $2 million CAD at $0.25 per share with over $700,000 CAD committed.

Approval and Hold Period Dates

The private placement is subject to TSX Venture Exchange final approval. All securities issued in connection with the final tranche are subject to a statutory hold period expiring March 1, 2027.